Anebulo Pharmaceuticals, Inc.
USD0.40
+0.00 (+0.00%)
CEO
Richard Anthony Cunningham
IPO Date
2021-05-07
Sector
Healthcare
Industry
Biotechnology
Exchange
OTC
Country
US
Open
$0.87
Prev. Close
$0.40
Day Low
$0.40
Day High
$0.87
52W Low
$0.01
52W High
$3.42
Market Cap
$0.02B
Volume
0.00M
| 115,037 |
| $1.02 |
| 7 Apr 2025 | Aryeh Jason | director | A-Award | Acquired | 25,000 | $1.02 |
| 7 Apr 2025 | Aryeh Jason | director | A-Award | Acquired | 4,964 | $1.02 |
| 10 Dec 2024 | Cunningham, Richard Anthony | director, officer: Chief Executive Officer | A-Award | Acquired | 254,433 | $1.56 |
| 17 Jun 2024 | Aryeh Jason | director | A-Award | Acquired | 41,667 | $2.10 |
| 17 Jun 2024 | Aryeh Jason | director | A-Award | Acquired | 2,482 | $2.10 |
| 8 Mar 2024 | Cundy Kenneth C | Chief Scientific Officer | A-Award | Acquired | 72,613 | $2.72 |
| 1 Mar 2024 | Cundy Kenneth C | Chief Scientific Officer | A-Award | Acquired | 72,613 | $2.78 |
| 11 Oct 2023 | Cunningham, Richard Anthony | director, officer: Chief Executive Officer | A-Award | Acquired | 600,000 | $3.03 |